文献速递心力衰竭与心肌病血脂与心血管预防

糖尿病心脏中的活性氧信号:治疗靶向的新前景

Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
PubMed 文献 · Heart · 2017-09-27

本文综述糖尿病心脏中活性氧(ROS)信号的作用,指出高血糖增加ROS生成是不良重构的核心机制,并探讨靶向ROS信号以预防或延缓心衰的治疗潜力。

要点

  • 糖尿病心脏在无缺血和高血压时即出现结构功能改变,与心衰进展独立相关。
  • 高达75%控制良好的糖尿病患者存在亚临床舒张功能障碍,与胶原堆积和炎症相关。
  • ROS生成增加是糖尿病心脏不良重构的核心机制,多个重构过程具有氧化还原敏感性。

核心结论

  • 糖尿病心脏中ROS生成增加是导致不良重构的核心机制,靶向ROS信号可能预防或延缓心衰进展。

研究设计与样本

  • 本文为综述,探讨糖尿病心脏中主要ROS来源(功能失调的NO合酶、线粒体、黄嘌呤氧化酶、NADPH氧化酶)的相对贡献及治疗靶向潜力。

主要发现

  • 糖尿病心脏在无缺血和高血压情况下发生特征性结构和功能改变,与心衰进展独立相关。
  • 显著胶原堆积伴炎症和细胞外基质广泛改变是心脏僵硬和亚临床舒张功能障碍的主要因素,估计发生于高达75%控制良好的糖尿病患者。
  • 实验和临床糖尿病均与氧化应激相关,后者在心肌病中起关键作用;炎症、血管新生、心肌细胞肥大和凋亡、纤维化及收缩功能障碍等过程均具有氧化还原敏感性。

临床怎么用

  • 针对ROS信号通路的新型药物和非药物方法可能修饰重构表型,用于预防和/或延缓心衰发生与进展。

局限性

  • 糖尿病心肌病作为独立实体仍存争议;特征性重构表型主要由微血管功能障碍还是心肌细胞代谢改变驱动尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite being first described 45 years ago, the existence of a distinct diabetic cardiomyopathy remains controversial. Nonetheless, it is widely accepted that the diabetic heart undergoes characteristic structural and functional changes in the absence of ischaemia and hypertension, which are independently linked to heart failure progression and are likely to underlie enhanced susceptibility to stress. A prominent feature is marked collagen accumulation linked with inflammation and extensive extracellular matrix changes, which appears to be the main factor underlying cardiac stiffness and subclinical diastolic dysfunction, estimated to occur in as many as 75% of optimally controlled diabetics. Whether this characteristic remodelling phenotype is primarily driven by microvascular dysfunction or alterations in cardiomyocyte metabolism remains unclear. Although hyperglycaemia regulates multiple pathways in the diabetic heart, increased reactive oxygen species (ROS) generation is thought to represent a central mechanism underlying associated adverse remodelling. Indeed, experimental and clinical diabetes are linked with oxidative stress which plays a key role in cardiomyopathy, while key processes underlying diabetic cardiac remodelling, such as inflammation, angiogenesis, cardiomyocyte hypertrophy and apoptosis, fibrosis and contractile dysfunction, are redox sensitive. This review will explore the relative contributions of the major ROS sources (dysfunctional nitric oxide synthase, mitochondria, xanthine oxidase, nicotinamide adenine dinucleotide phosphate oxidases) in the diabetic heart and the potential for therapeutic targeting of ROS signalling using novel pharmacological and non-pharmacological approaches to modify specific aspects of the remodelling phenotype in order to prevent and/or delay heart failure development and progression.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wilson AJ, Gill EK, Abudalo RA, et al. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Heart. 2017. PMID: 28954833. doi:10.1136/heartjnl-2017-311448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。